| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1191/0961203305LU2122OA |
| P698 | PubMed publication ID | 15803936 |
| P50 | author | Manuel Ramos-casals | Q42646201 |
| Josep Font | Q73474655 | ||
| P2860 | cites work | A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients | Q28346817 |
| Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil | Q28376115 | ||
| Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases | Q33346990 | ||
| Mycophenolate mofetil in the treatment of autoimmune HCV-associated haematological disorders showing steroid resistance or dependence | Q33349902 | ||
| Long-term follow-up study of 168 patients with immune thrombocytopenia. Implications for therapy. | Q33478153 | ||
| Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy | Q33483427 | ||
| Chronic Idiopathic Thrombocytopenic Purpura in the Elderly | Q33488894 | ||
| Autoimmune thrombocytopenia associated with hepatitis C virus infection | Q33502899 | ||
| Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience | Q33654989 | ||
| New therapeutic strategies for hepatitis C. | Q34490190 | ||
| Impact of immunosuppressive therapy on recurrence of hepatitis C. | Q34936148 | ||
| Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection | Q35121285 | ||
| Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis. | Q36496437 | ||
| Molecular mechanisms of action of ribavirin | Q38016839 | ||
| Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations | Q40483846 | ||
| Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections. | Q40668883 | ||
| HCV-related fibrosis progression following liver transplantation: increase in recent years | Q41732518 | ||
| The association between hepatitis C infection and survival after orthotopic liver transplantation | Q42672810 | ||
| Hepatitis C-associated glomerulonephritis--a novel therapeutic approach | Q43030618 | ||
| Hepatitis C and mycophenolate mofetil--a clarification | Q43037540 | ||
| Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis | Q43041401 | ||
| Long-term outcome of hepatitis C infection after liver transplantation | Q43046814 | ||
| A longitudinal analysis of hepatitis C virus replication following liver transplantation | Q43047520 | ||
| Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. | Q43519797 | ||
| A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients | Q43604925 | ||
| Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. | Q43643377 | ||
| Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection. | Q43675792 | ||
| Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial | Q43710489 | ||
| Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation. | Q43831138 | ||
| A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. | Q43859527 | ||
| First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV. | Q44101383 | ||
| Use of mycophenolate mofetil in kidney transplant recipients with viral hepatitis infection: is it justified? | Q44256961 | ||
| Outcome of de novo hepatitis C virus infection in heart transplant recipients | Q44598997 | ||
| Hepatitis C and renal transplantation in the era of modern immunosuppression | Q44625419 | ||
| Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis | Q44839339 | ||
| Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation | Q47939750 | ||
| Hemolytic anemia and the treatment of chronic hepatitis C. | Q50587624 | ||
| New concepts in treatment protocols for severe systemic vasculitis. | Q50587893 | ||
| Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. | Q52979941 | ||
| Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. | Q54435526 | ||
| Cryoglobulinemia | Q56907690 | ||
| A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1 | Q57704207 | ||
| Mycophenolate mofetil | Q71778184 | ||
| Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group | Q73088409 | ||
| [Prevalence and clinical significance of hepatitis C virus infection in systemic autoimmune diseases] | Q74043108 | ||
| Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients | Q74593569 | ||
| Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation | Q77983005 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | s64-72 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Mycophenolate mofetil in patients with hepatitis C virus infection | |
| P478 | volume | 14 Suppl 1 |
| Q85799519 | Cryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetil |
| Q42207241 | Cytomegalovirus retinitis: a rare but preventable cause of blindness in dermatology patients |
| Q37364331 | Hepatitis C infection and chronic renal diseases |
| Q36496970 | Hepatitis C virus and its renal manifestations: a review and update |
| Q35731058 | Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection |
| Q81522234 | Mycophenolate mofetil |
| Q36420503 | Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells |
| Q37690527 | Suppression of autophagy by mycophenolic acid contributes to inhibition of HCV replication in human hepatoma cells |
| Q28282350 | Treating HCV with ribavirin analogues and ribavirin-like molecules |
| Q35714749 | Treatment of HCV patients before and after renal transplantation |
| Q37087258 | Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis |
Search more.